A researcher argues Alzheimer's is driven by chronic infections like Lyme disease and mold, not just neurodegeneration. He claims to have reduced phosphorylated tau 63% in nine weeks, compared to 23% over seven years with conventional drugs. He says standard neurologists don't test for these pathogens.
Chapters
We're in the middle of an Alzheimer's epidemic where the NIH said that 42% of people over 55 years old are now going to become demented. They looked at autopsy studies of Alzheimer's patients and they would find biofilms, amyloid, and phosphorylated tau in the brains. So there was an association, but they couldn't say causation. This is the first time I proved causation by completely reversing this biomarker. And this woman was, by the way, was sick for 15 years. And the symptoms got better. Her joint pain got better. Rheumatoid factor reversed because it wasn't rheumatoid arthritis. It was from the Lyme bacteria driving rheumatoid factors. So here we have an Alzheimer's epidemic where I found that all 16 mSIDS factors are associated with it. The Cochrane report is saying, hey, we don't have anything good out there to treat. And the drugs that are used for it, they lowered phosphorylated tau by 23% in almost 7 years. I lowered it by 63% in 9 weeks. Yeah. And that was because it was the infection driving the amyloid and the phosphorylated tau. And unfortunately, you go to a neurologist, they're not even gonna check you for Lyme disease or Bartonella or mold when you have Alzheimer's disease.